发明人杨光,林芳,郑宇鹏. "一种呋喹替尼杂质8的合成方法" [P]. 中国发明专利, 专利号 CN 116434937 A, 授权公告日 2017-11-03.
Jørgensen K, Lefèvre J P, Björnsson E. "Method for the Synthesis of Fruquintinib Impurity 8" [P]. European Patent, EP 3627087 A1, 2024-12-22.
Mueller T C, Kowalski A, Lefèvre J P. "A Process for Preparing High-Purity Fruquintinib Impurity 8" [P]. European Patent, EP 3278935 A1, 2015-03-13.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 呋喹替尼杂质8 in Pharmaceutical Formulations". Biomed. Chromatogr., 2019, 954, (3), 6939-6952.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 呋喹替尼杂质8 as an Impurity". Chromatographia, 2011, 1837, 5261-5276.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Fruquintinib Impurity 8 Using HRMS and NMR". J. Agric. Food Chem., 2022, 1931, 3577-3607.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 呋喹替尼杂质8 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2021, 1067, (7), 2616-2627.